Boots boss quits after float is shelved by ailing Walgreens
Seb James, CEO of Boots since 2018, will leave the company in November, as its owner postponed a multibillion-pound sale for the second time. James will become the group CEO of Veonet, the European ophthalmology clinic chain.
Head of Boots pharmacy chain reportedly will depart as Walgreens struggles
Head of Boots pharmacy chain reportedly will depart as owner Walgreens struggles.
Walgreens Stock Collapses on Weak Outlook. Is Now the Time to Buy?
Walgreens shares plunged after the company lowered its EPS guidance. The company has been experiencing severe drug reimbursement pressures, hurting margins and profitability.
Down Over 60%, Is Walgreens Boots Alliance a Bad-News Buy?
Walgreens Boots Alliance stock fell hard after the company reported fiscal third-quarter results on June 27. Management has lowered its earnings expectations twice this year.
Walgreens Stock Price Collapses
Walgreens (NASDAQ: WBA) has experienced a significant decline in 2023, with shares down over 55% year-to-date, trading at levels last seen in 1998.
What's Behind Walgreens Stock Plunge: What Investors Can Do Next
After years of a downtrend in their price, shares of Walgreens Boots Alliance Inc. NASDAQ: WBA have thrown in the towel this time. In a single day, the stock is down over 25% in a sign that can't be taken in any other way than a ‘run' message.
Walgreens' Challenges With Stores And VillageMD Prove Just How Tough Healthcare Is
Walgreens is one of the most celebrated names in the retail pharmacy space, boasting innovation and convenience for its customers. However, in its latest earnings report, the company announced a tough financial environment and outlook, citing “a worse-than-expected U.S. consumer environment.
Boots CEO James quits after Walgreens' plans for sale stalls, Sky News reporter says
Boots chain CEO Sebastian James quit as CEO after owner Walgreens Boots Alliance's plans for a 5 billion pound ($6.32 billion) sale or stock market listing of the company stalled, Sky News reporter Mark Kleinman said in a post on X on Saturday.
Shareholder Rights Advocates at Levi & Korsinsky Investigate Walgreens Boots Alliance, Inc. (WBA) Regarding Possible Securities Fraud Violations
NEW YORK, NY / ACCESSWIRE / June 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Walgreens Boots Alliance, Inc. ("Walgreens Boots Alliance, Inc.") (NASDAQ:WBA) concerning possible violations of federal securities laws. On June 27, 2024, following CEO Rosalind Brewer's abrupt resignation in September 2023, Walgreens announced 3Q24 financial results and reduced its revenue guidance for the fourth quarter and full fiscal year 2024.
Walgreens Boots Alliance: Maybe I Was Wrong
Walgreens Boots Alliance stock has declined over 83% from its all-time high, underperforming the S&P 500 and competitor CVS Health. The company reported mediocre third quarter results, but lowered full-year guidance once again. Although the stock seems extremely cheap, I would pass on an investment at this point.
Watch These Levels in Walgreens' Stock Price After Plunge to 27-Year Low
Walgreens Boots Alliance (WBA), which currently leads the S&P 500's worst-performing stocks in the first half of 2024, plummeted more than 22% to a 27-year low on Thursday after the pharmacy chain and healthcare provider missed profit estimates and slashed its outlook amid weakening consumer demand.
